Cargando…
Modifier genes and variation in cystic fibrosis
The availability of molecular tools to carry out genotyping has led to a flurry of association studies between specific genes and clinical indices of disease or disease susceptibility. Human studies, for the most part, have a limited number of subjects available, precluding whole genome types of app...
Autor principal: | Drumm, Mitchell L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002068/ https://www.ncbi.nlm.nih.gov/pubmed/11686874 http://dx.doi.org/10.1186/rr47 |
Ejemplares similares
-
Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis
por: Henderson, Lindsay B., et al.
Publicado: (2012) -
Genetic Influences on Cystic Fibrosis Lung Disease Severity
por: Weiler, Colleen A., et al.
Publicado: (2013) -
Taking stock of gene therapy for cystic fibrosis
por: Stern, Myra, et al.
Publicado: (2000) -
Genetic Modifiers of Cystic Fibrosis–Related Diabetes
por: Blackman, Scott M., et al.
Publicado: (2013) -
Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity
por: Taylor-Cousar, Jennifer L., et al.
Publicado: (2009)